Index of reports
> Cases with Nausea (162)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Methotrexate where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 162 Next >>
Possible Methotrexate side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 2.5 mg/day
Possible Methotrexate side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Prednisone
Dosage: 2.5 mg/day
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Possible Methotrexate side effects in female
Reported by a physician from Sweden on 2012-08-20
Patient: female
Reactions: Nausea, Progressive Multifocal Leukoencephalopathy, Hepatic Enzyme Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine
Dosage: 150 mg/day
Administration route: Oral
Indication: Polymyositis
Cyclophosphamide
Dosage: 100 mg/day
Administration route: Oral
Indication: Polymyositis
Methotrexate
Dosage: 20 mg/week
Indication: Polymyositis
Methylprednisolone
Prednisone
Dosage: 10mg daily
Prednisone
Dosage: 17.5 mg/day
Administration route: Oral
Prednisone
Dosage: 60 mg/day
Prednisone
Dosage: 2.5 mg/day
Prednisone
Dosage: 40 mg/day
Indication: Polymyositis
Possible Methotrexate side effects in 26 year old female
Reported by a consumer/non-health professional from Canada on 2012-08-16
Patient: 26 year old female
Reactions: Back Pain, Nausea, Ulcerative Keratitis
Drug(s) suspected as cause:
Methotrexate
Dosage: inj
Orencia
Dosage: last infusion on 11-may-2012,7aug12 lot # 2c80093 exp dt se2014 no of inf 6
Indication: Rheumatoid Arthritis
Start date: 2012-04-12
Other drugs received by patient: Vitamin D; Oxycodone HCL; Plaquenil; Calcium; Prednisone TAB; Amlodipine; Omeprazole; Indocin; Folic Acid
Possible Methotrexate side effects in 21 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient: 21 year old female
Reactions: Hyperbilirubinaemia, Fatigue, Nausea, Hyperglycaemia, Asthenia, Abdominal Pain Upper
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Leucovorin Calcium
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: high dose
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Prednisone TAB
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Possible Methotrexate side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: 61 year old female
Reactions: Mucosal Inflammation, Nausea, Pyrexia, Diffuse Large B-Cell Lymphoma Recurrent, Oral Herpes
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Methotrexate
Indication: Diffuse Large B-Cell Lymphoma
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Methotrexate side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-08-13
Patient: 65 year old female
Reactions: Myositis, Dysphagia, Nausea, Ataxia, Hemiparesis, Hepatic Enzyme Increased, Dysarthria, Fatigue, Nystagmus, Balance Disorder, Quadriparesis, Vertigo, Arthritis, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Azathioprine Sodium
Dosage: 150 mg, qd
Administration route: Oral
Cyclophosphamide
Dosage: 100 mg, qd
Administration route: Oral
Methotrexate
Dosage: 20 mg, qw
Prednisone TAB
Dosage: 40 mg, qd
Administration route: Oral
Prednisone TAB
Dosage: 17.5 mg, qd
Administration route: Oral
Prednisone TAB
Dosage: 10 mg, qd
Administration route: Oral
Prednisone TAB
Dosage: 40 mg, qd
Administration route: Oral
Prednisone TAB
Dosage: 12.5 mg, qd
Administration route: Oral
Other drugs received by patient: Methylprednisolone; Glucocorticoids; Heparin
Possible Methotrexate side effects in 22 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 22 year old male, weighing 93.1 kg (204.8 pounds)
Reactions: Abdominal Pain, Vomiting, Nausea, Pain, Hyperglycaemia, Unresponsive To Stimuli, Pancytopenia, Disorientation, Pyrexia, Toxicity To Various Agents, Convulsion, Myalgia, Arthralgia, Chest Pain
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Possible Methotrexate side effects in female
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-20
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Abdominal Pain, Nausea, Flatulence
Drug(s) suspected as cause:
Methotrexate
Indication: Rheumatoid Arthritis
Methotrexate
Dosage: 25 mg, per week
Start date: 2012-02-01
End date: 2012-06-01
Possible Methotrexate side effects in
Reported by a physician from United Kingdom on 2012-07-17
Patient:
Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole
Possible Methotrexate side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir
Possible Methotrexate side effects in 10 year old female
Reported by a physician from Korea, Democratic People's Republic of on 2012-07-06
Patient: 10 year old female
Reactions: Vomiting, Wernicke's Encephalopathy, Nausea, Malnutrition, Mental Status Changes, Convulsion
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Methotrexate
Other drugs received by patient: Cisplatin; Adriamycin PFS
Possible Methotrexate side effects in
Reported by a physician from United States on 2012-07-05
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Dyspnoea, Stomatitis, Vomiting, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone Sodium Phosphate
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Prednisone
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Other drugs received by patient: Filgrastim; Unknown Medication; Leucovorin Calcium
Possible Methotrexate side effects in
Reported by a physician from United States on 2012-06-28
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Vomiting, Stomatitis, Dyspnoea, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Respiratory Failure, Diarrhoea, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Methotrexate side effects in male
Reported by a individual with unspecified qualification from United States on 2012-06-28
Patient: male, weighing 99.5 kg (218.9 pounds)
Reactions: Vomiting, Fatigue, Nausea, Blood Triglycerides Increased, Asthenia
Drug(s) suspected as cause:
Methotrexate
Dosage: 570 mg
PEG-L-Asparaginase (K-H)
Dosage: 5600 unit
Vincristine Sulfate
Dosage: 4 mg
Possible Methotrexate side effects in 14 year old male
Reported by a individual with unspecified qualification from Japan on 2012-06-25
Patient: 14 year old male
Reactions: Dysphagia, Vomiting, Nausea, Hypophagia, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167 mg
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42 mg
Indication: Bone Sarcoma
Etoposide
Dosage: 84 mg
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200
Indication: Bone Sarcoma
Methotrexate
Dosage: 28 mg
Indication: Bone Sarcoma
Possible Methotrexate side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Stomatitis, Vomiting, Dyspnoea, Nausea, Gastrointestinal Toxicity, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-22
Patient: 14 year old male
Reactions: Vomiting, Nausea, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Indication: Bone Sarcoma
Doxorubicin HCL
Indication: Bone Sarcoma
Etoposide
Dosage: 2,6 courses
Indication: Bone Sarcoma
Ifosfamide
Dosage: inj.2,6 courses.
Indication: Bone Sarcoma
Methotrexate
Possible Methotrexate side effects in female
Reported by a physician from France on 2012-06-21
Patient: female
Reactions: Weight Decreased, Nausea, Musculoskeletal Pain, Drug Intolerance, Spondylitis, Antinuclear Antibody Positive, Fatigue, Diarrhoea, Systemic Lupus Erythematosus, Hypoalbuminaemia, Arthritis, Decreased Appetite
Drug(s) suspected as cause:
Humira
Indication: Crohn's Disease
Start date: 2010-03-01
Methotrexate
Dosage: weekly
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-16
Other drugs received by patient: Folic Acid
Possible Methotrexate side effects in 62 year old female
Reported by a physician from Canada on 2012-06-19
Patient: 62 year old female
Reactions: Vomiting, Nausea, Condition Aggravated, Pancytopenia
Drug(s) suspected as cause:
Hydroxychloroquine Sulfate
Indication: Lupus Nephritis
Methotrexate
Administration route: Oral
Indication: Condition Aggravated
Prednisone
Indication: Lupus Nephritis
Possible Methotrexate side effects in 47 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-19
Patient: 47 year old male
Reactions: Mucosal Inflammation, Rash Generalised, Vomiting, Nausea, Pancytopenia, Pyrexia, Toxicity To Various Agents
Drug(s) suspected as cause:
Methotrexate
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-14
Patient: 14 year old male
Reactions: Vomiting, Nausea, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167mg
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42mg
Indication: Bone Sarcoma
Etoposide
Dosage: 84mg
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200mg
Indication: Bone Sarcoma
Methotrexate
Dosage: 28mg
Indication: Bone Sarcoma
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-14
Patient: 14 year old male
Reactions: Vomiting, Nausea, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167mg
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42mg
Indication: Bone Sarcoma
Etoposide
Dosage: 84mg
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200mg
Indication: Bone Sarcoma
Methotrexate
Dosage: 28mg
Indication: Bone Sarcoma
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-14
Patient: 14 year old male
Reactions: Vomiting, Nausea, Hearing Impaired, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167mg
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42mg
Indication: Bone Sarcoma
Etoposide
Dosage: 84mg
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200mg
Indication: Bone Sarcoma
Methotrexate
Dosage: 28mg
Indication: Bone Sarcoma
Possible Methotrexate side effects in 14 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-11
Patient: 14 year old male
Reactions: Dysphagia, Vomiting, Nausea, Oesophageal Stenosis
Drug(s) suspected as cause:
Cisplatin
Dosage: 167 mg, unk
Indication: Bone Sarcoma
Doxorubicin HCL
Dosage: 42 mg, unk
Indication: Bone Sarcoma
Etoposide
Dosage: 84 mg, unk
Indication: Bone Sarcoma
Ifosfamide
Dosage: 4200 mg, unk
Indication: Bone Sarcoma
Methotrexate
Dosage: 28 mg, unk
Indication: Bone Sarcoma
Possible Methotrexate side effects in female
Reported by a consumer/non-health professional from Canada on 2012-06-06
Patient: female
Reactions: Soft Tissue Infection, Nausea, Diarrhoea, Chills, Swelling, Pyrexia, Herpes Virus Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-18
Simponi
Indication: Rheumatoid Arthritis
Start date: 2010-02-02
Possible Methotrexate side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-06-06
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Rheumatoid Arthritis, Weight Increased, Nausea, Blood Triglycerides Increased, Depression, Abdominal Pain Upper
Drug(s) suspected as cause:
Methotrexate
Indication: Rheumatoid Arthritis
Start date: 2005-01-01
End date: 2011-01-01
Remicade
Dosage: 3 ampoules each
Indication: Rheumatoid Arthritis
Start date: 2012-03-01
Remicade
Start date: 2012-05-16
Remicade
Dosage: 2 ampoules each
Start date: 2005-01-01
Possible Methotrexate side effects in 80 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-06
Patient: 80 year old female, weighing 59.0 kg (129.8 pounds)
Reactions: Abdominal Pain, Vomiting, Nausea, Drug Interaction, Transaminases Increased, Cholelithiasis, Alveolitis, Malaise, Respiratory Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Amlodipine
Dosage: 5 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-01
End date: 2009-05-15
Cordanum
Dosage: 50 mg, qd
Administration route: Oral
Indication: Tachyarrhythmia
Start date: 2008-11-01
End date: 2009-05-04
Falithrom
Dosage: 3 mg, qd
Administration route: Oral
Indication: Tachyarrhythmia
Start date: 2008-11-01
End date: 2009-05-04
Methotrexate
Dosage: 10 ml, qd
Indication: Rheumatoid Arthritis
Start date: 2008-11-01
End date: 2009-05-04
Omeprazole
Dosage: 20 mg, qd
Administration route: Oral
Indication: Prophylaxis Against Gastrointestinal Ulcer
Start date: 2008-11-01
End date: 2009-05-03
Ramipril
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2000-01-01
Seroquel
Dosage: 25 mg, qd
Administration route: Oral
Indication: Restlessness
Start date: 2008-11-01
Simvastatin
Dosage: 40 mg, qd
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2008-11-01
End date: 2009-05-05
Torsemide
Dosage: 200 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2008-11-01
Other drugs received by patient: Ferrous Sulfate TAB; Digitoxin TAB; Xipamide; Prednisolone; Prednisolone; Folic Acid; Prednisolone; Actonel 35 Plus; Prednisolone; Prednisolone
Possible Methotrexate side effects in 47 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-04
Patient: 47 year old male
Reactions: Mucosal Inflammation, Rash Generalised, Vomiting, Nausea, Pancytopenia, Pyrexia, Drug Dispensing Error
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Possible Methotrexate side effects in 68 year old female
Reported by a physician from United States on 2012-06-01
Patient: 68 year old female
Reactions: Oral Discomfort, Dysgeusia, Vomiting, Nausea, Decreased Appetite
Drug(s) suspected as cause:
Enbrel
Dosage: 50 mg, weekly
Indication: Rheumatoid Arthritis
Start date: 2012-04-24
Methotrexate
Dosage: 22.5 mg, weekly
Administration route: Oral
Methotrexate Sodium
Dosage: tried injections briefly
Other drugs received by patient: Zofran; Folic Acid
Page 1 Next >>
|